Lack of significant cross-reactivity between Leishmania serology and mycobacteriosis in patients infected with HIV-1

Clinical Microbiology and Infection

Volumn 5, Issue 5, 1999, Pages 253-255

  Pérez Molina, José A ^a   Torres, Lorenzo ^a   Ruiz, María J ^a   Rivera, Marisa ^a   Martín Rabadán, Pablo ^a   Bouza, E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Diagnosis; HIV; Indirect immunofluorescence; Leishmania; MAC; Tuberculosis

Indexed keywords

ARTICLE; CROSS REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA; LEISHMANIASIS; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; SEROLOGY; TUBERCULOSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM COMPLEX (MAC); MYCOBACTERIUM AVIUM-INTRACELLULARE; MYCOBACTERIUM INTRACELLULARE;

EID: 0345280736     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00137.x     Document Type: Article

References (10)

1. Miralles P, Moreno S. Pérez-Tascón M. Cosín J, Díaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995; 20: 872-5.
2. Montalbán C, Calleja JL, Erice A, et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus. J Infect 1990; 21: 261-70.
3. Dereure J, Reynes J, Pratlong F, et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull WHO 1995; 73: 245-6.
4. Gallardo JA, Pineda JA, Macías J, Torronteras R, Lissen E. Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Trop Med Hyg 1996; 90: 383.
5. López-Vélez R, Turrientes MC, Gómez-Mampaso E. Reacciones cruzadas de la serología a Leishmania infantum por immunofluorescencia indirecta en pacientes HIV+ y HIV- con tuberculosis activa. Enferm Infecc Microbiol Clin 1998; 16: 130-1.
6. Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol 1995; 21(2): 123-52.
7. Sanchís Bayarri V. Algunos aspectos sobre el serodiagnóstico del Kala-Azar y variaciones de su fórmula leucocitaria. Acta Pediatr Español 1956; 13: 966-76.
8. Bates PA, Robertson CD, Tetey L, Coombs GH. Axenic cultivation and characterization ot Leishmania mexicana amastigote-like forms. Parasitology 1992; 105: 193-6.
9. Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154: 1003-10.
10. López-Vélez R, Pérez-Molina JA, Guerrero A, et al. Clinico-epidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. Am J Trop Med Hyg 1998; 58(4): 436-43.